Medical technology to gain some benefit from EU SME unit
This article was originally published in Clinica
Executive Summary
Some small- to medium-sized medical technology manufacturers (SMEs) with products on the drug/device borderline will now be able to benefit from new services and reduced fees for EU regulatory services.